Bulletin de Périodique
European Addiction Research , Vol.19, n°6 - October 2013
Paru le :
01/10/2013
Année
2013
Page(s) :
283-346
Langue(s) :
Anglais
Note de contenu :
CONTENTS:
- Abstinence versus agonist maintenance treatment: An outdated debate? [Editorial]. Uchtenhagen A., p. 283-286.
- The experience of long-term opiate maintenance treatment and reported barriers to recovery: a qualitative systematic review. Notley C., Blyth A., Maskrey V., Craig J., Holland R., p. 287-298.
- Attentional bias for alcohol-related stimuli among belief based and non-belief based non-drinkers. Moss A.C., Albery I.P., Siddiqui I., Rycroft N., p. 299-302.
- A logical fallacy: Commentary on Moss et al. Field M., p. 303-304.
- Commentary on Moss et al. Franken I.H., p. 305-306.
- Association between neuropeptide Y gene polymorphisms and alcohol dependence: A case-control study in two independent populations. Bhaskar L.V., Thangaraj K., Kumar K.P., Pardhasaradhi G., Singh L., Rao V.R., p. 307-313.
- Building a European consensus on minimum quality standards for drug treatment, rehabilitation and harm reduction. Schaub M.P., Uchtenhagen A., EQUS Expert Group, p. 314-324.
- Efficacy and tolerability of baclofen in substance use disorders: a systematic review. Agabio R., Preti A., Gessa G.L., p. 325-345.
- Abstinence versus agonist maintenance treatment: An outdated debate? [Editorial]. Uchtenhagen A., p. 283-286.
- The experience of long-term opiate maintenance treatment and reported barriers to recovery: a qualitative systematic review. Notley C., Blyth A., Maskrey V., Craig J., Holland R., p. 287-298.
- Attentional bias for alcohol-related stimuli among belief based and non-belief based non-drinkers. Moss A.C., Albery I.P., Siddiqui I., Rycroft N., p. 299-302.
- A logical fallacy: Commentary on Moss et al. Field M., p. 303-304.
- Commentary on Moss et al. Franken I.H., p. 305-306.
- Association between neuropeptide Y gene polymorphisms and alcohol dependence: A case-control study in two independent populations. Bhaskar L.V., Thangaraj K., Kumar K.P., Pardhasaradhi G., Singh L., Rao V.R., p. 307-313.
- Building a European consensus on minimum quality standards for drug treatment, rehabilitation and harm reduction. Schaub M.P., Uchtenhagen A., EQUS Expert Group, p. 314-324.
- Efficacy and tolerability of baclofen in substance use disorders: a systematic review. Agabio R., Preti A., Gessa G.L., p. 325-345.
Cote :
Abonnement
Dépouillements
Ajouter le résultat à votre sélection
C. NOTLEY ;
A. BLYTH ;
V. MASKREY ;
J. CRAIG ;
R. HOLLAND
|
2013
Dans European Addiction Research (Vol.19, n°6, October 2013) Article : Périodique
Dans European Addiction Research (Vol.19, n°6, October 2013) Article : Périodique
Background/Aim: To inform understanding of the experience of long-term opiate maintenance and identify barriers to recovery.
Methods: A qualitative systematic review. Results: 14 studies in 17 papers, mainly from the USA (65%), met inclusion c[...]
M. P. SCHAUB ;
A. UCHTENHAGEN ;
EQUS Expert Group
|
2013
Dans European Addiction Research (Vol.19, n°6, October 2013) Article : Périodique
Dans European Addiction Research (Vol.19, n°6, October 2013) Article : Périodique
Background/Aims: The Study on the Development of an EU Framework for Minimum Quality Standards and Benchmarks in Drug Demand Reduction (EQUS) has set up an inventory of quality standards and initiated a consensus-building process, aiming at esta[...]
R. AGABIO ;
A. PRETI ;
G. L. GESSA
|
2013
Dans European Addiction Research (Vol.19, n°6, October 2013) Article : Périodique
Dans European Addiction Research (Vol.19, n°6, October 2013) Article : Périodique
Background: It has been reported that baclofen, a drug used in the treatment of spasticity, reduces the severity of withdrawal symptoms and substance use disorders (SUDs) for some psychoactive drugs.
Aims and Methods: To evaluate the effective[...]
Historique